首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Moderate Zinc Supplementation During Prolonged Steroid Therapy Exacerbates Bone Loss in Rats
Authors:Rozy Kamal  S C Bansal  N Khandelwal  D V Rai  D K Dhawan
Institution:1. Centre for Nuclear Medicine, University Institute of Emerging Areas in Science and Technology (UIEAST), Panjab University, Chandigarh, 160014, India
2. Department of Radiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India
3. Department of Biomedical Engineering, Shobhit University of Engineering and Technology, Meerut, 250110, India
4. Department of Biophysics,, Panjab University, Chandigarh, 160014, India
Abstract:The present study was conducted to understand the influence of zinc on bone mineral metabolism in prednisolone-treated rats. Disturbance in bone mineral metabolism was induced in rats by subjecting them to prednisolone treatment for a period of 8 weeks. Female rats aged 6–8 weeks weighing 150 to 200 g were divided into four treatment groups, viz., normal control, prednisolone-treated (40 mg/kg body weight orally, thrice a week), zinc-treated (227 mg/L in drinking water, daily), and combined prednisolone?+?zinc-treated groups. Parameters such as changes in mineral levels in the bone and serum, bone mineral density (BMD), bone mineral content (BMC), and bone 99m-technetium-labeled methylene diphosphonate (99mTc-MDP) uptake were studied in various treatment groups. Prednisolone treatment caused an appreciable decrease in calcium levels both in the bone and serum and also in bone dry weight, BMC, and BMD in rats. Prednisolone-treated rats when supplemented with zinc showed further reduction in calcium levels, bone dry weight, BMD, and BMC. The study therefore revealed that moderate intake of zinc as a nutritional supplement during steroid therapy could enhance calcium deficiency in the body and accelerate bone loss.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号